Mashiba et al, Int. Jour. Immunother., VI, 221-224, 1990.* |
Mashiba et al, Cancer Letters, 55 , 183-188, 1990.* |
Guclu et al., “Binding of Chlorambucil with Antitumor Globulins and its Effect on Drug and Antibody Activities” Europ. J. Cancer, vol. 12:95-100 (1976). |
Martens et al., “Ditiocarb: Decomposition in Aqueous Solution and Effect of the Volatile Product on Its Pharmacological Use” Journal of Pharmaceutical Sciences vol. 82:379-383 (1993). |
Aptaker et al., “Serum Albumin Level as a Predictor of Geriatric Stroke Rehabilitation Outcome” Arch. Phys. Med. Rehabil., 75:80-84 (1994). |
Avontuur et al., “Inhibition of Nitric Oxide Synthesis Causes Myocardial Ischemia in Endotoxemic Rats” Cir. Res., 76:418-425 (1995). |
Beckman et al., “Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide” Proc.Natl. Acad. Sci., USA 87:1620-1624 (1990). |
Bredt and Snyder, “Nitric Oxide: A Physiologic Messenger Molecule” Neuron, 8:3-11. |
Caldwell et al., “NG-Nitro-L-arginine methyl ester protects lipid peroxidation in the gerbil following cerebral ischaemia” Eur. J. Pharmacol., 285:203-206 (1995). |
Chan, “Role of Oxidants in Ischemic Brain Damage” Stroke, 27:1127-29 (1996). |
Dawson and Dawson, “Protection of the Brain from Ischemia” Cerebrovascular Disease, H. Hunt Batjer, ed., Lippincott-Raven Publishers, Philadelphia, Ch. 25 pp. 319-325 (1997). |
Diener et al., “Lubeluzole in Acute Ischemic Stroke: A Double-blind, Placebo-Controlled Phase II Trial” Stroke, 27:76-81 (1996). |
Diket et al., “Nitric oxide inhibition causes intruterine growth retardation and hind-limb disruptions in rats” Am. J. Obstet. Gynecol., 171:1243-1250 (1994). |
Dizdaroglu and Bergtold, “Characterization of Free Radical-Induced Base Damage in DNA at Biologically Relevant Levels” Anal. Biochem., 156:182-188 (1986). |
Faraci and Brian, “Nitric Oxide and the Cerebral Circulation” Stroke, 25:692-703 (1994). |
Fisher et al., “New Magnetic Resonance Techniques for Evaluating Cerebrovascular Disease” Ann. Neurol., 32:115-122 (1992). |
Haber and Weiss, “The Catalytic Decomposition of Hydrogen Peroxide by Iron Salts*” Proc. R. Soc. Ser. A., 147:332-351 (1934). |
Haley, “Safety Study of Tirilazad Mesylate in Patients With Acute Ischemic Stroke (STIPAS)” Stroke, 25:418-423 (1994). |
Halliwell, “Albumin—An Important Extracellular Antioxidant?” Biochem. Pharmacol., 37:569-571 (1988). |
Hassan et al., “Biosynthesis and Regulation of Superoxide Dismutases” Free Radical Biol. Med., 5:377-385, (1988). |
He et al., “Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion” Am. J. Physiol. 265:H252-256 (1993). |
Hearse et al., “The Oxygen Paradox and the Calcium Paradox: Two Facets of the Same Problem?” J. Mol. Cell. Cardiol., 10:641-668 (1978). |
Huie and Padmaja, “The Reaction of no with Superoxide” Free Radical Res. Commun., 18:195-199 (1993). |
Iadecola et al., “Inducible Nitric Oxide Synthase Gene Expression in Brain Following Cerebral Ischemia” J. Cereb. Blood Flow and Metab., 15:378-384 (1995). |
Komarov and Lai, “Detection of nitric oxide production in mice by spin-rapping electron paramagnetic resonance spectroscopy” Biochim. Biophys. Acta, 1272:29-36 (1995). |
Kumura et al., “Elevation of Plasma Nitric Oxide End Products During Focal Cerebral Ischemia and Reperfusion in the Rat” J. Cereb. Blood Flow and Metab., 14:487-491 (1994). |
Lai and Komarov, “Spin trapping of nitric oxide produced in vivo in setic-shock mice” FEBS Letters, 345:120-124 (1994). |
Lai and Piette, “Hydroxyl Radical Production Involved in Pipid Peroxidation of Rat Liver Microsomes*” Biochem. Biophys. Res. Comun., 78:51-59 (1977). |
Lenzi et al., “Early Treatment of Strok With Monosialoganglioside GM-1” Stroke, 5:1552-1558 (1994). |
Lin et al., “Effect of Brain Edema on Infarct Volume in a Focal Cerebral Ischemia Model in Rats” Stroke 24:117-121 (1993). |
Malinski et al., “Nitric Oxide-Induced Blockade of NMDA Receptors” J Cereb.Blood Flow Metab., 13:355-358 (1993). |
Manzoni et al., “Nitric Oxide Measured by Porphyrinic Microsensor in Rat Brain After Transient Middle Cerebral Artery Occlusion” Neuron, 8:653-662 (1992). |
Matsui et al., “Beneficial Effect of Prolonged Administration of Albumin on Ischemic Cerebral Edema and Infarction after Occlusion of Middle Cerebral Artery in Rats” Neurosurgery, 33:293-300 (1993). |
Meldrum, “Cytoprotective therapies in stroke” Current Opinion in Neurol., 8:15-23 (1995). |
Moncada and Higgs, “The L-Arginine—Nitric Oxide Pathway” New Engl. J. Med., 329:2002-2012 (1993). |
Nathan, “Nitric oxide as a secretory prodcut of mammalian cells” FASEB J., 6:3051-3064 (1992). |
Reisinger et al., “Inhibition of HIV progression by dithiocarb” Lancet, 335:679-82 (1990). |
Samdani et al., “Nitric Oxide Synthase in Models of Focal Ischemia” Stroke 28:1283-1288 (1997). |
Sato et al.. “EPR spin-trapping study of nitric oxide formation during bilateral carotid occlusion in the rat” Biochim. Biophys. Acta, 1181:195-197 (1993). |
Sunderman, “Efficacy of Sodium Diethyldithiocarbamate (Dithiocarb) in Acute Nickel Carbonyl Poisoning*” Annals Clin. Res., 3:182-185 (1971). |
Warach et al., “Fast magnetic resonance diffusion-weighted imaging of acute human stroke” Neurol., 42:1717-1723 (1992). |
Wityk and Stern, “Ischemic stroke: Today and tomorrow” Crit. Care Med., 22:1278-1293. |
Zhang et al., “Aminoguanidine Ameliorates and L-Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery Occlusion” Stroke, 27:317-323 (1996). |